Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Chen

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Photochemistry and Photobiology|July 6, 2024
Therapeutic effect of NEO400, perillyl alcohol conjugated to linoleic acid, in a mouse model of UV-induced skin damageStephen Swenson, Catalina Silva-Hirschberg, Liliana Freeland, et al.
Cancers|March 13, 2024
Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and TemozolomideHannah Hartman-Houstman, Steve Swenson, Radu O Minea, et al.
Frontiers in Cellular Neuroscience|December 27, 2016
Heterocellular Contacts with Mouse Brain Endothelial Cells <i>Via</i> Laminin and α6β1 Integrin Sustain Subventricular Zone (SVZ) Stem/Progenitor Cells PropertiesAlexandra I Rosa, Sofia Grade, Sofia D Santos, et al.
Journal of the American Heart Association|May 20, 2014
Argonaute-2 promotes miR-18a entry in human brain endothelial cellsRaquel Ferreira, Tiago Santos, Arun Amar, et al.
Journal of Biomedical Science|August 19, 2015
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivoThomas C Chen, Hee-Yeon Cho, Weijun Wang, et al.
Cancer Letters|April 29, 2017
A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cellsThomas C Chen, Jiali Yu, Eslam Nouri Nigjeh, et al.
Blood|August 27, 2005
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxibAdel Kardosh, Nathaniel Soriano, Yen-Ting Liu, et al.
Oncotarget|December 2, 2015
Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulationLi Xie, Xingguo Song, Wei Guo, et al.
Cancers|July 24, 2021
Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid LeukemiaAxel H Schönthal, Steve Swenson, Radu O Minea, et al.
Neurosurgical Focus|May 20, 2006
Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericinVinay Gupta, Yuzhuang S Su, Weijun Wang, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Photochemistry and Photobiology|July 6, 2024
Therapeutic effect of NEO400, perillyl alcohol conjugated to linoleic acid, in a mouse model of UV-induced skin damageStephen Swenson, Catalina Silva-Hirschberg, Liliana Freeland, et al.
Cancers|March 13, 2024
Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and TemozolomideHannah Hartman-Houstman, Steve Swenson, Radu O Minea, et al.
Frontiers in Cellular Neuroscience|December 27, 2016
Heterocellular Contacts with Mouse Brain Endothelial Cells <i>Via</i> Laminin and α6β1 Integrin Sustain Subventricular Zone (SVZ) Stem/Progenitor Cells PropertiesAlexandra I Rosa, Sofia Grade, Sofia D Santos, et al.
Journal of the American Heart Association|May 20, 2014
Argonaute-2 promotes miR-18a entry in human brain endothelial cellsRaquel Ferreira, Tiago Santos, Arun Amar, et al.
Journal of Biomedical Science|August 19, 2015
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivoThomas C Chen, Hee-Yeon Cho, Weijun Wang, et al.
Cancer Letters|April 29, 2017
A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cellsThomas C Chen, Jiali Yu, Eslam Nouri Nigjeh, et al.
Blood|August 27, 2005
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxibAdel Kardosh, Nathaniel Soriano, Yen-Ting Liu, et al.
Oncotarget|December 2, 2015
Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulationLi Xie, Xingguo Song, Wei Guo, et al.
Cancers|July 24, 2021
Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid LeukemiaAxel H Schönthal, Steve Swenson, Radu O Minea, et al.
Neurosurgical Focus|May 20, 2006
Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericinVinay Gupta, Yuzhuang S Su, Weijun Wang, et al.
Pageof 15